Vanderbilt Center for Technology Transfer and Commercialization

09/07/2026

Vanderbilt Institute for Clinical and Translational Research (VICTR) leaders Wesley Self and Jill Pulley share how VICTR brings together clinical care, scientific discovery, technology and collaboration to advance research that improves health and transforms patient care.

🔗 Read more:

Research and art both approach the world with a fresh perspective. This art gallery features work by undergraduate student artists who participated in the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program. Supported by the Burroughs Wellcome Fund,....

09/04/2026

Through Cowrite the Future, Vanderbilt University and the Nashville Innovation Alliance are showcasing how researchers, entrepreneurs and industry leaders are turning the city’s creativity and collaboration into real-world impact. The campaign highlights a growing innovation ecosystem and a shared ambition to make Nashville a destination for people and ideas shaping what’s next.

🔗 Read more:

For decades, Nashville’s story to the outside world has been deeply rooted in music and the music industry. But across the city in labs, startups and research centers, a different kind of creativity is at work, one that’s measured in patents, prototypes and problems solved—and its story dese...

09/03/2026

The U.S. Food and Drug Administration cleared Heartvue.Proton (K260811), an AI-powered software platform for cardiac MRI built on technology developed by Jeffrey Dendy, a Vanderbilt Health cardiologist and imaging specialist, through Heartvue.AI.

🔗 Read more about the regulatory milestone: https://www.vanderbilt.edu/cttc/2026/09/02/fda-clears-cardiac-imaging-software-developed-with-vanderbilt-researchers/

09/02/2026

From major research grants and cancer breakthroughs to an $87M technology partnership and recognition of biomedical excellence, Vanderbilt continues to advance the future of health care.

🗞️ In case you missed them, check out these Vanderbilt Health news: https://news.vumc.org/

09/01/2026

From expanding Vanderbilt’s public impact and exploring breakthrough ideas across research and society to advancing engineering innovation and earning international recognition through the Fulbright Program, Vanderbilt continues to turn discovery and collaboration into meaningful impact.

🗞️ Check out these Vanderbilt University news: https://news.vanderbilt.edu/

08/31/2026

In FY26, Vanderbilt CTTC reached all-time highs in invention disclosures and licensing transactions, while growing revenue and expanding a startup pipeline that continues to bring more faculty into entrepreneurship.

Behind that momentum are Vanderbilt University and Vanderbilt Health researchers taking steps to translate their discoveries into real-world impact, with 196 researchers among this year’s disclosures doing so for the first time.

The outcomes reflect a growing community imagining how their work can reach people beyond campus. 🔗 Read more: https://news.vanderbilt.edu/2026/08/17/records-made-to-be-broken-vu-center-for-technology-transfer-and-commercialization-posts-another-year-of-strong-innovation-outcomes/

07/15/2026

⏰ Today's the day! Registration closes today for the Vanderbilt Life Science Showcase: AI in Translational Research.

One of the featured sessions asks a question that's on everyone's mind:
Will AI replace experimental science?

Join a cross-disciplinary panel featuring leaders from Vanderbilt, Eli Lilly, Amazon Web Services, and NashBio as they debate AI's role in discovery, validation, and the future of translational research.

Featured panelists:
• Linus S. Lin, PhD (Eli Lilly)
• Colleen Niswender, PhD (Vanderbilt)
• Elizabeth Ann Stringer, PhD (NashBio)
• Ken Lau, PhD (Vanderbilt)
• Firas Wehbe, MD, PhD, FAMIA (Amazon Web Services)

Whether you're a researcher, entrepreneur, or industry professional, you won't want to miss this timely discussion.

📅 Thursday, July 23, 2026
🚨 Registration closes today: https://ow.ly/3Ovk50ZnMAK

07/13/2026

Innovation happens when academia and industry come together.

At this year's Vanderbilt Life Science Showcase: AI in Translational Research, we're excited to welcome industry leaders Bob Chen, PhD (Genentech), Francis J. Prael III, PhD (Bristol Myers Squibb), Cody Heiser, PhD (Regeneron Pharmaceuticals), and Doug Applegate, PhD (Novartis).

These experts will share how AI is transforming drug discovery, computational biology, molecular profiling, and translational research—offering valuable perspectives on bringing breakthrough science from the lab to patients.

Join researchers, innovators, entrepreneurs, and industry professionals for a day of insightful discussions and networking at the intersection of AI and life sciences.

📅 Thursday, July 23, 2026
⏰ Registration closes July 15—don't miss your chance to be part of the conversation.

https://ow.ly/rreu50ZmY0e

07/09/2026

Meet the Vanderbilt researchers taking the stage at this year's Vanderbilt Life Science Showcase: AI in Translational Research.

Join Benjamin P. Brown, MD, PhD; Allison Walker, PhD; Ivelin Georgiev, PhD; and Carlos Oliver, PhD, along with fellow researchers, innovators, and industry leaders, as we explore how artificial intelligence is accelerating the path from scientific discovery to real-world impact.

This showcase is an opportunity to hear directly from Vanderbilt faculty at the forefront of AI-enabled life science innovation, connect with industry partners, and discover emerging technologies shaping the future of translational research.

📅 Thursday, July 23, 2026

Registration closes July 15, so be sure to reserve your spot before the deadline:

https://ow.ly/AGlf50Zm2rx

07/07/2026

🎤 Meet the experts taking the stage at the Vanderbilt Life Science Showcase: AI in Translational Research!

Join us for an incredible lineup of leaders from academia, biotech, pharma, and technology who are shaping the future of AI in life sciences.
Featured speakers include:

🔹 Susan Margulies, PhD (Vanderbilt University)
🔹 Benjamin P. Brown, MD, PhD (Vanderbilt University)
🔹 Allison Walker, PhD (Vanderbilt University)
🔹 Ivelin Georgiev, PhD (Vanderbilt University Medical Center)
🔹 Carlos Oliver, PhD (Vanderbilt University)
🔹 Ken Lau, PhD (Vanderbilt University)
🔹 Bob Chen, PhD (Genentech)
🔹 Francis Prael, PhD (Bristol Myers Squibb)
🔹 Cody Heiser, PhD (Regeneron Pharmaceuticals)
🔹 Douglas Applegate, PhD (Novartis)
🔹 Linus S. Lin, PhD (Lilly Research Laboratories)
🔹 Colleen M. Niswender, PhD (Vanderbilt University)
🔹 Elizabeth Ann Stringer, PhD (NashBio)
🔹 Firas Wehbe, MD, PhD, FAMIA (Amazon Web Services)

Together, they'll discuss how AI is transforming translational research—from accelerating drug discovery and development to improving patient outcomes through data-driven innovation and fostering new industry collaborations.

📅 Don't miss this opportunity to hear from these outstanding thought leaders. Registration is still open—reserve your spot today!

Register here:
https://ow.ly/gcIK50ZlcEw